Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies.
Wichroski M, Liu SQ, Zasadil LM, Benci JL, Gedeon PC, Condon KJ, Joshi S, Posy S, Carlson P, Maier A, Shen J, Kureshi R, Amako Y, Wang T, Powles RL, Li Y, Lai T, Katsyv I, Qiu H, Qi H, Wong J, Zhao D, Banas D, Onorato J, Locke G, Chen X, Chou WC, Cook E, Witt AE, Barbieri CM, Zhang H, Olsen JB, Font Tello A, Drokhlyansky E, Grünenfelder DC, Chupak L, Longmire TA, Jones JC, Hollmann TJ, Kugler DG, Feder JN, Bueno R, Wain J, Sivakumar P, Liu Y, Dougan SK, Paweletz CP, Barbie DA, Lees E.
Wichroski M, et al. Among authors: barbieri cm.
Cancer Immunol Res. 2025 Sep 2;13(9):1342-1362. doi: 10.1158/2326-6066.CIR-25-0156.
Cancer Immunol Res. 2025.
PMID: 40506249
Free PMC article.